Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

2-phenyl-1h-benzimidazole-4-formic ether derivative serving as PARP (poly(ADP-ribose)polymerase) inhibiting agent

A technology of benzimidazole and methyl formate, applied in the field of medicinal chemistry, can solve problems such as no drugs

Inactive Publication Date: 2012-04-18
CHINA PHARM UNIV
View PDF12 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although there are various structural types of such inhibitors at present, and at least seven compounds are in clinical research, but there is still no drug on the market in the past 30 years, so further improve the novelty of its structural type, and look for good properties and activities in various aspects. compound, it is very necessary

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 2-phenyl-1h-benzimidazole-4-formic ether derivative serving as PARP (poly(ADP-ribose)polymerase) inhibiting agent
  • 2-phenyl-1h-benzimidazole-4-formic ether derivative serving as PARP (poly(ADP-ribose)polymerase) inhibiting agent
  • 2-phenyl-1h-benzimidazole-4-formic ether derivative serving as PARP (poly(ADP-ribose)polymerase) inhibiting agent

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0068] Synthesis of key intermediate 2,3-diaminobenzoic acid methyl ester (II)

[0069] (a) 3-nitro-2-carbamoylbenzoic acid

[0070] Dissolve 3-nitrophthalic anhydride (1.0g, 5.2mmol) in 20ml of dry tetrahydrofuran, stir at room temperature to dissolve, slowly add an appropriate amount of ammonia water dropwise, a white solid precipitates, continue to stir at room temperature for 4h, let stand for 20min, filter A white solid was obtained, left to stand, the residual solvent was evaporated to dryness, and recrystallized with dilute hydrochloric acid (10%) to obtain 0.9 g of a white solid, yield 87%, mp 208-208.5°C. 1 H-NMR (DMSO-d 6 )d: 7.56 (1H, brs, -NH 2 ), 7.68-7.73 (1H, t, Ar-H), 7.79 (1H, brs, -NH 2 ), 8.10-8.13 (1H, m, Ar-H), 8.16-8.19 (1H, m, Ar-H), 13.45 (1H, brs, -COOH); MS m / z: 211.0 [M+H] + , 233.0[M+Na] + , 249.0[M+K] + ; IR(KBr, cm -1 ): 3463, 3188, 1668, 1529.

[0071] (b) 2-Amino-3-nitrobenzoic acid

[0072] Dissolve 5g of KOH in 20ml of water to prepar...

Embodiment 2

[0079] Synthesis of 2-(4-hydroxyphenyl)-1H-benzimidazole-4-carboxylic acid methyl ester

[0080] Methyl 2,3-diaminobenzoate (0.28g, 1.6mmol) and p-hydroxybenzaldehyde (0.18g, 1.5mmol) were dissolved in 20ml of methanol and an appropriate amount of NaHSO was added 3 , Heated to reflux for 6h, filtered the reaction solution, and distilled off methanol. Add appropriate amount of silica gel to make sand and apply column chromatography (petroleum ether: ethyl acetate = 1:2) to separate about 0.4 g of light yellow homologue, yield 81%, mp 257-258°C. 1 H-NMR (CDCl 3 )d: 3.98 (3H, s, -OCH 3 ), 6.93-6.95 (2H, m, Ar-H), 7.30-7.33 (1H, m, Ar-H), 7.79-7.81 (1H, m, Ar-H), 7.90-7.91 (1H, m, Ar-H) -H), 8.13-8.14 (2H, m, Ar-H); MS m / z: 269.3 [M+H] + ; IR(KBr, cm -1 ): 3417, 1695, 1440, 1280; Elementary Analysis: C 15 h 12 N 2 o 3 0.3H 2 O, calcd (C 65.8, H 4.64, N 10.23), Found (C 66.10, H 4.48, N 9.84).

Embodiment 3

[0082] Synthesis of 2-(4-bromophenyl)-1H-benzimidazole-4-carboxylic acid methyl ester

[0083] Refer to Example 2 for the method. Yield: 72%, mp 123-124°C. 1 H-NMR (CDCl 3 )d: 4.04 (3H, s, -CH 3 ), 7.26-7.37 (1H, m, Ar-H), 7.67-7.70 (2H, m, Ar-H), 7.92-7.97 (1H, m, Ar-H), 8.01-8.02 (2H, m, Ar-H -H), 8.03-8.05 (1H, m, Ar-H); MS m / z: 333.0 [M+H] + , 353.0[M+Na] + ; IR(KBr, cm -1 ): 3446, 1703, 1282, 750; Elementary Analysis: C 15 h 11 N 2 o 2 , calcd (C 54.40, H 3.34, N 8.45), Found (C 54.00, H 3.67, N 8.23).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a novel 2-phenyl-1H-benzimidazole-4-formic ether PARP (Poly(ADP-Ribose)Polymerase) inhibiting agent (shown as a formula I), and discloses a preparation method of a compound and medical application thereof. The compound can be used for preparing anticancer medicaments, anti-ischemia-reperfusion injury medicaments, anti-inflammation medicaments, anti-degenerative disease injury medicaments and all treatment medicaments for diseases of which the PARP-1 / 2 inhibiting activities can be improved.

Description

technical field [0001] The invention relates to the field of medicinal chemistry, in particular to a novel class of 2-phenyl-1H-benzimidazole-4-carboxylate PARP inhibitors. The invention also discloses the preparation method and medical application of the compound. Background technique [0002] Poly ADP-ribose polymerases (poly(ADP-ribose) polymerases, PARPs) are a protein superfamily in eukaryotic cells, containing at least 18 subtypes. Their common feature is that the catalytic region at the C-terminus can catalyze the cleavage of the substrate NAD + to nicotinamide and ADP-ribose, and use the latter to poly-ADP-ribosylate itself and other target proteins. PARP enzyme is involved in many physiological processes of the body, such as DNA repair, gene transcription, cell cycle progression, cell death, chromosome stability, etc. (Pharmacological Research, 2005, 52: 25-33). Among them, PARP-1 and PARP-2 are mainly involved in DNA damage repair, and the function of PARP-2 is ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D235/18A61K31/4184A61P35/00A61P9/10A61P29/00A61P19/02A61P25/00A61P1/00A61P3/10A61P25/16A61P43/00
Inventor 孙宏斌沈超柳军赵娜张陆勇
Owner CHINA PHARM UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com